Rifapentine and Isoniazid TB Preventive Therapy (3HP) for Children Taking Dolutegravir-based Antiretroviral Treatment (DOLPHIN KIDS)
Clinical trial NCT05122767 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05122767
- Sponsor
- The Aurum Institute NPC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-24
- Primary completion
- 2025-07-04
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.